The most common side effects include sensation of warmth, redness and pain at the injection site, mild diarrhea, nausea, headaches, pain in joints and a feeling of swelling in the whole body
This pathway interacts with dopamine signaling, but also involves a separate opioid-mediated reward process that GLP-1 medications may not directly target
From here, one of three scenarios typically occur: Your medication is covered, and you can start your prescription fairly quickly (possibly pending a day or two for the pharmacy to order the medicine if its not in stock)
Yes, rapid improvement in glycemic control with any diabetes medication can occasionally trigger treatment-induced neuropathy of diabetes, which presents as acute painful neuropathy and typically improves over time
Data from this manuscript were published in abstract form in the proceedings of the 75th Annual Meeting of the American Diabetes Association, Boston, MA, USA, 59 June 2015
Relative to comparators, the risk for any of the commonly used cardiovascular end points was estimated to be below 1.0, and for both MACE-4 and MACE-3 (myocardial infarction, stroke, and all-cause death), the upper bounds of the confidence interval calculated around the hazard ratio were decidedly 8.5 %